Effect of smoking on circulating angiogenic factors in high risk pregnancies

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Jeyabalan, Arun ^a   Powers, Robert W ^a   Clifton, Rebecca G ^b   van Dorsten, Peter ^c   Hauth, John C ^d   Klebanoff, Mark A ^e   Lindheimer, Marshall D ^f   Sibai, Baha ^g   Landon, Mark ^h   Miodovnik, Menachem ⁱ  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^h THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENDOGLIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; ANGIOGENIC FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK PATIENT; HIGH RISK PREGNANCY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MULTIPLE PREGNANCY; PATIENT ASSESSMENT; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; BLOOD; PREGNANCY; SMOKING;

ADULT; ANGIOGENESIS INDUCING AGENTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY, HIGH-RISK; SMOKING;

EID: 78149427051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013270     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention (2004) Smoking during pregnancy - United States, 1990-2002. MMWR.
2. Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML (1999) Effects of smoking during pregnancy. Five meta-analyses. American Journal of Preventive Medicine 16: 208-215.
3. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC (1999) Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. American Journal of Obstetrics & Gynecology 181: 1026-1035.
4. England L, Zhang J (2007) Smoking and risk of preeclampsia: a systematic review. Frontiers in Bioscience 12: 2471-2483.
5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation 111: 649-658.
6. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine 12: 642-649.
7. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine 350: 672-683.
8. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, et al. (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New England Journal of Medicine 355: 992-1005.
9. Belgore FM, Lip GY, Blann AD (2000) Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. British Journal of Biomedical Science 57: 207-213.
10. Schmidt-Lucke C, Belgore F, Reinhold D, Ansorge S, Klein HU, et al. (2005) Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers. International Journal of Cardiology 100: 207-212.
11. Levine RJ, Qian C, Yu K, Sibai B, Karumanchi SA (2006) Circulating angiogenic factors in smokers and non-smokers during normotensive pregnancy. American Journal of Obstetrics & Gynecology (supplement) 195: S37.
12. Powers RW, Roberts JM, Cooper KM, Gallaher MJ, Frank MP, et al. (2005) Maternal serumsoluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. American Journal of Obstetrics & Gynecology 193: 185-191.
13. Jeyabalan A, Powers RW, Durica AR, Harger G, Roberts JM, et al. (2008) Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. American Journal of Hypertension 21: 943-947.
14. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, et al. (1998) Low- Dose Aspirin to Prevent Preeclampsia in Women at High Risk. New England Journal of Medicine 338: 701-705.
15. Powers RW, Jeyabalan A, Clifton RG, VanDorsten P, Hauth J, et al. (2010) Soluble fms-like tyrosine kinase (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One In press.
16. Klebanoff MA, Levine RJ, Clemens JD, DerSimonian R, Wilkins DG (1998) Serum cotinine concentration and self-reported smoking during pregnancy. American Journal of Epidemiology 148: 259-262.
17. Mehendale R, Hibbard J, Fazleabas A, Leach R (2007) Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. American Journal of Obstetrics and Gynecology 197: 363.e1-5.
18. Sinclair SH (2006) Diabetic retinopathy: the unmet needs for screening and a review of potential solutions. Expert Review of Medical Devices 3: 301-313.
19. Chappell LC, Enye S, Seed P, Briley AL, Poston L, et al. (2008) Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 51: 1002-1009.
20. Coonrod DV, Hickok DE, Zhu K, Easterling TR, Daling JR (1995) Risk factors for preeclampsia in twin pregnancies: a population-based cohort study. Obstetrics and Gynecology 85: 645-650.
21. Martin CL, Hall MH, Campbell DM (2000) The effect of smoking on preeclampsia in twin pregnancy. British Journal of Obstetrics and Gynecology 107: 745-749.
22. Ness RB, Zhang J, Bass D, Klebanoff MA, Ness RB, et al. (2008) Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth. American Journal of Epidemiology 168: 427-433.
23. Janakiraman V, Gantz M, Maynard S, El-Mohandes A (2009) Association of cotinine levels and preeclampsia among African-American women. Nicotine & Tobacco Research 11: 679-684.
24. Engel SM, Janevic TM, Stein CR, Savitz DA (2009) Maternal smoking, preeclampsia, and infant health outcomes in New York City, 1995-2003. American Journal of Epidemiology 169: 33-40.
25. Contreras KR, Kominiarek MA, Zollinger TW (2010) The impact of tobacco smoking on perinatal outcome among patients with gestational diabetes. Journal of Perinatology 30: 319-323.
26. Cundy T, Slee F, Gamble G, Neale L (2002) Hypertensive disorders of pregnancy in women with Type 1 and Type 2 diabetes. Diabetic Medicine 19: 482-489.
27. Khoury JC, Miodovnik M, Buncher CR, Kalkwarf H, McElvy S, et al. (2004) Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes. Journal of Maternal-Fetal and Neonatal Medicine 15: 44-5015.
28. Wikstrom A-K, Stephansson O, Cnattingius S (2010) Tobacco Use During Pregnancy and Preeclampsia Risk: Effects of Cigarette Smoking and Snuff. Hypertension 55: 1254-1259.
29. Karumanchi SA, Levine RJ (2010) How Does Smoking Reduce the Risk of Preeclampsia? Hypertension 55: 1100-1101.
30. England LJ, Grauman A, Qian C, Wilkins DG, Schisterman EF, et al. (2007) Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine and Tobacco Research 9: 1005-1013.